Paul Andrew Moore, Chief Scientific Officer at Zymeworks Inc. (ZYME), sold 19,120 shares at $22.67 ($433K) on 2026-01-12, disclosed to the SEC on 2026-01-12.
Open-market sale of $433k ZYME by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.67 | 9,560 | $217K | 50.0% |
| 2 | $22.67 | 9,560 | $217K | 50.0% |
| Total | $22.67 avg | 19,120 | $433K | 100% |
| Filing → |
| ZYME | SELL | 2024-01-08 | $106K | — | Filing → |